Calcium Gluconate 2.5% solution for inhalation, 5mL pre-filled syringes, Rx only, Compounded by P...

FDA Drug Recall #D-0054-2024 — Class II — October 2, 2023

Recall Summary

Recall Number D-0054-2024
Classification Class II — Moderate risk
Date Initiated October 2, 2023
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Pine Pharmaceuticals, LLC
Location Tonawanda, NY
Product Type Drugs
Quantity 881 pre-filled syringes

Product Description

Calcium Gluconate 2.5% solution for inhalation, 5mL pre-filled syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide within the United States

Lot / Code Information

Lot #: 70363, Exp. Date 03/20/2024

Other Recalls from Pine Pharmaceuticals, LLC

Recall # Classification Product Date
D-0059-2024 Class II Lidocaine-phenylephrine 1%-1.5% 1mL Single Dose... Oct 2, 2023
D-0057-2024 Class II Cefuroxime 4mg /0.4 mL (10 mg/mL), 1mL syringe,... Oct 2, 2023
D-0058-2024 Class II Moxifloxacin in Balanced Salt Solution 400 mcg/... Oct 2, 2023
D-0055-2024 Class II Tropi-Phen (Tropicamide 1% phenylephrine HCl 2.... Oct 2, 2023
D-0061-2024 Class II Calcium chloride Solution for Intravenous Injec... Oct 2, 2023

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.